Show simple item record

dc.contributor.authorSezgin Özcan, Didem
dc.contributor.authorDalyan, Meltem
dc.contributor.authorErgül, Serhat
dc.contributor.authorÜnsal Delialioğlu, Sibel
dc.contributor.authorKöseoğlu, Belma Füsun
dc.date.accessioned2019-12-31T11:29:27Z
dc.date.available2019-12-31T11:29:27Z
dc.date.issued2019en_US
dc.identifier.citationSezgin Özcan, D., Dalyan, M., Ergül, S., Ünsal Delialioğlu, S. ve Köseoğlu, B. F. (2019). Evaluation of vitamin D levels in patients with breast cancer-related lymphedema: An observational cross-sectional study. Turkish Journal of Osteoporosis, 25(3), 105-110. https://doi.org/10.4274/tod.galenos.2019.35119en_US
dc.identifier.issn2147-2653
dc.identifier.urihttps://doi.org/10.4274/tod.galenos.2019.35119
dc.identifier.urihttps://hdl.handle.net/20.500.12511/4838
dc.description.abstractObjective: The aim of our study was to compare plasma vitamin D levels between patients with breast cancer-related lymphedema (BCRL) and healthy population, and also to investigate the effects of socio-demographic and clinical factors and lymphedema severity on vitamin D levels. Materials and Methods: Eighty patients with BCRL [mean age 55.5 +/- 8.9 (36-81)] and age- and sex-matched 80 healthy controls [mean age 53.7 +/- 7.4 (32-70)] who were not on calcium or vitamin D supplementation were included in the study. Socio-demographic and clinical characteristics of the subjects were questioned. Plasma 25-Hydroxyvitamin D3, calcium, phosphorus, alkaline phosphatase (ALP), and parathormone (PTH) levels were evaluated. Lymphedema was classified as stage 0, I, II, or III. Results: The mean duration of lymphedema was 23.5 +/- 13.8 months. Comparisons revealed lower vitamin D levels and higher PTH and ALP levels in patients with BCRL than healthy controls. As a result of multivariate regression analysis, a significant relationship was revealed between vitamin D levels and age, breast cancer stage, and disease duration in patients with BCRL. Vitamin D levels were significantly lower and PTH levels were significantly higher in stage 3 lymphedema patients compared to stage 1. Conclusion: Vitamin D levels were detected lower in patients with lymphedema than healthy controls. Although vitamin D levels were found to be lower in patients with severe lymphedema, the multivariate regression analysis revealed that the severity of lymphedema does not have a significant effect on vitamin D levels.en_US
dc.language.isoengen_US
dc.publisherGalenos Yayıncılıken_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAttribution NonCommercial 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/*
dc.subjectVitamin Den_US
dc.subjectBreast Canceren_US
dc.subjectLymphedemaen_US
dc.subjectParathormoneen_US
dc.titleEvaluation of vitamin D levels in patients with breast cancer-related lymphedema: An observational cross-sectional studyen_US
dc.typearticleen_US
dc.relation.journalTurkish Journal of Osteoporosisen_US
dc.departmentİstanbul Medipol Üniversitesi, Sağlık Bilimleri Fakültesi, Fizyoterapi ve Rehabilitasyon Bölümüen_US
dc.authorid0000-0003-0246-3001en_US
dc.identifier.volume25en_US
dc.identifier.issue3en_US
dc.identifier.startpage105en_US
dc.identifier.endpage110en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.doi10.4274/tod.galenos.2019.35119en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

info:eu-repo/semantics/openAccess
Except where otherwise noted, this item's license is described as info:eu-repo/semantics/openAccess